Opexa Therapeutics Receives European Patent Notification for T-Cell Vaccine
THE WOODLANDS, Texas--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today announced that it has received notification under Rule 51(4) from the Examining Division of the European …